CTSZ and neoplasm: We have also analyzed CTSZ mRNA expression in terms of different clinical parameters related to the malignancy status, and we found that the group with intermediate/high risk according to the ISUP grade group for the resected tumor (Supplementary Figure S3A) presented a 71% decrease compared to the low-risk group (p=0.050).